165 related articles for article (PubMed ID: 35476141)
1. Human papillomavirus anogenital screening in solid organ transplant recipients: a narrative review.
Papastamelos C; Linder M
Arch Gynecol Obstet; 2023 Apr; 307(4):1277-1283. PubMed ID: 35476141
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus-related cancer risk for solid organ transplant recipients during adult life and early prevention strategies during childhood and adolescence.
Nailescu C; Ermel AC; Shew ML
Pediatr Transplant; 2022 Nov; 26(7):e14341. PubMed ID: 35808949
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus infection in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Chin-Hong PV; Reid GE;
Clin Transplant; 2019 Sep; 33(9):e13590. PubMed ID: 31077438
[TBL] [Abstract][Full Text] [Related]
5. Human Papillomavirus in Kidney Transplant Recipients.
Chin-Hong PV
Semin Nephrol; 2016 Sep; 36(5):397-404. PubMed ID: 27772624
[TBL] [Abstract][Full Text] [Related]
6. Are Health Care Professionals Prepared to Implement Human Papillomavirus Testing? A Review of Psychosocial Determinants of Human Papillomavirus Test Acceptability in Primary Cervical Cancer Screening.
Tatar O; Wade K; McBride E; Thompson E; Head KJ; Perez S; Shapiro GK; Waller J; Zimet G; Rosberger Z
J Womens Health (Larchmt); 2020 Mar; 29(3):390-405. PubMed ID: 31479381
[No Abstract] [Full Text] [Related]
7. [Cervical cancer screening in Switzerland - current practice and future challenges].
Untiet S; Schmidt N; Low N; Petignat P
Ther Umsch; 2013 Apr; 70(4):223-30. PubMed ID: 23535549
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer in Ethiopia: a review of the literature.
Derbie A; Mekonnen D; Nibret E; Misgan E; Maier M; Woldeamanuel Y; Abebe T
Cancer Causes Control; 2023 Jan; 34(1):1-11. PubMed ID: 36242682
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of abnormal cervical cytology and human papillomavirus-related lesions in patients with organ transplantation: 11-year experience at a single institution.
Tanaka Y; Ueda Y; Kakuda M; Kubota S; Matsuzaki S; Nakagawa S; Egawa-Takata T; Matsuzaki S; Kobayashi E; Yoshino K; Kimura T
Int J Clin Oncol; 2016 Aug; 21(4):730-734. PubMed ID: 26694812
[TBL] [Abstract][Full Text] [Related]
10. Cervical Cancer: Prevention and Early Detection.
Kessler TA
Semin Oncol Nurs; 2017 May; 33(2):172-183. PubMed ID: 28343836
[TBL] [Abstract][Full Text] [Related]
11. Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient.
Guo F; Hirth JM; Berenson AB
J Womens Health (Larchmt); 2017 Oct; 26(10):1114-1122. PubMed ID: 28841084
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus (HPV) and cervical dysplasia in adult female cystic fibrosis (CF) lung transplant recipients.
Thornton C; Somayaji R; Chu A; Parkins MD
Thorax; 2022 Jun; 77(6):625-627. PubMed ID: 35121654
[TBL] [Abstract][Full Text] [Related]
13. Primary Care Physicians' Adherence to Expert Recommendations for Cervical Cancer Screening and Prevention in the Context of Human Papillomavirus Vaccination.
Malo TL; Perkins RB; Lee JH; Vadaparampil ST
Sex Transm Dis; 2016 Jul; 43(7):438-44. PubMed ID: 27322046
[TBL] [Abstract][Full Text] [Related]
14. Concordance of Anyplex™ II HPV HR assays with reference HPV assays in cervical cancer screening: Systematic review.
Biazin H
J Virol Methods; 2022 Mar; 301():114435. PubMed ID: 34919974
[TBL] [Abstract][Full Text] [Related]
15. Understanding Sexual and Gender Minority Populations and Organ-Based Screening Recommendations for Human Papillomavirus-Related Cancers.
Jodry D; Obedin-Maliver J; Flowers L; Jay N; Floyd S; Teoh D; Conageski C; Downs L; Khan MJ
J Low Genit Tract Dis; 2023 Oct; 27(4):307-321. PubMed ID: 37729043
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis.
Tatar O; Thompson E; Naz A; Perez S; Shapiro GK; Wade K; Zimet G; Gilca V; Janda M; Kahn J; Daley E; Rosberger Z
Prev Med; 2018 Nov; 116():40-50. PubMed ID: 30172799
[TBL] [Abstract][Full Text] [Related]
17. Prevention of cervical cancer in HIV-seropositive women from developing countries through cervical cancer screening: a systematic review.
Mapanga W; Girdler-Brown B; Feresu SA; Chipato T; Singh E
Syst Rev; 2018 Nov; 7(1):198. PubMed ID: 30447695
[TBL] [Abstract][Full Text] [Related]
18. [Screening for cervical cancer, human papillomavirus (HPV) vaccination].
Schaff Z; Járay B
Magy Onkol; 2022 Dec; 66(4):325-330. PubMed ID: 37161827
[TBL] [Abstract][Full Text] [Related]
19. Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists.
Perkins RB; Anderson BL; Gorin SS; Schulkin JA
Am J Prev Med; 2013 Aug; 45(2):175-81. PubMed ID: 23867024
[TBL] [Abstract][Full Text] [Related]
20. Papanicolaou smear findings in solid-organ transplant recipients compared with normal subjects according to the Bethesda 2001 system.
Ok Atılgan A; Tepeoğlu M; Haberal AN; Durukan E; Kuşcu E; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():219-22. PubMed ID: 25894158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
